JFL Life Sciences Limited (NSEI: JFLLIFE)
Health Care · Pharmaceuticals · IN
Rs10.90
-17.42% today · -22.7% 1Y
JFL Life Sciences Limited (NSEI: JFLLIFE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.76M.
Over the last twelve months the share price has lost 22.7%, trading between 8.55 and 15.40.
Tweenvest scores JFL Life Sciences Limited across four factors: quality 58/100, value 75/100, growth 98/100. Its strongest factor is growth.
JFLLIFE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.76M
- Revenue (TTM)
- $13.84M
- P/E
- 5.33
- EPS
- 2.05
- Dividend yield
- —
- Beta (5Y)
- -0.26
- 52-week high
- Rs15.40
- 52-week low
- Rs8.55
- Avg volume (3M)
- —
- Shares outstanding
- 33.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.00 | +0.05% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.25 | -0.20% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.13 | +0.21% |
Figures last refreshed Aug 18, 2026.